VTGN
VistaGen Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.24
−1.38%Margins
Gross margin
84.6%
EBITDA margin
-2689.9%
EBIT margin
-2784.3%
Net margin
-2702.6%
FCF margin
-2489.9%
-276.2%
Return on equity
-189.2%
Return on assets
-275.7%
Return on invested capital
0.06x
Asset turnover
-$62.3M
Cash from operations
$0.72
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026